Range uncertainty in proton therapy due to variable biological effectiveness.
about
Proton radiobiologyA phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potentialNew challenges in high-energy particle radiobiology.Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, PolandTowards Achieving the Full Clinical Potential of Proton Therapy by Inclusion of LET and RBE ModelsExtension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.Treatment planning optimisation in proton therapy.Variations in the Processing of DNA Double-Strand Breaks Along 60-MeV Therapeutic Proton Beams.Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton TherapyMicrodosimetric calculation of relative biological effectiveness for design of therapeutic proton beams.Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particlesA new formalism for modelling parameters α and β of the linear quadratic model of cell survival for hadron therapy.A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.Physical and biological factors determining the effective proton range.A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.Applications of High-Throughput Clonogenic Survival Assays in High-LET Particle Microbeams.Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.A Simpler Energy Transfer Efficiency Model to Predict Relative Biological Effect for Protons and Heavier Ions.Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.Impact of variable RBE on proton fractionation.Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.Proton and helium ion radiotherapy for meningioma tumors: a Monte Carlo-based treatment planning comparison.Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.Relative biological effectiveness in a proton spread-out Bragg peak formed by pencil beam scanning mode.Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.Optimization of Monte Carlo particle transport parameters and validation of a novel high throughput experimental setup to measure the biological effects of particle beams.Rapid RBE-Weighted Proton Radiation Dosimetry Risk Assessment.Relative biological effectiveness in proton beam therapy - Current knowledge and future challenges.Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectivesProton Relative Biological Effectiveness - Uncertainties and Opportunities
P2860
Q27025061-0C66D5DD-3E31-40DB-97E4-99E316776ABCQ30370355-677C00DA-3EFA-46D6-B205-640DB0F596E4Q33274824-88DCF82C-3E6F-40A9-A736-8E88F0D4ECCAQ33782346-7DE7CDDF-DAB7-4AC8-AC40-6D295589D362Q34455876-4D5177BF-3BDA-4286-827F-01FD1AC969F6Q35237539-3397AE4A-D86E-4087-8897-BFDE04C9C9E0Q35878652-4467012D-F8ED-4C0D-A09A-7731D477B25DQ36294862-F9F1AA6F-03F9-497E-854D-AEE23255C2F2Q36823746-31637921-56C4-4A7E-8482-1914DB184F5FQ36833350-326A4BC0-DB14-4C74-9F84-F02C88F72D1BQ36833677-F35C2BF2-A3C6-40E2-81B3-EF29B05699AEQ37108051-5C9D9ED3-5AA2-4707-B280-F3ED2F32CAABQ38612774-2D48FAA8-4BCA-42A6-B400-AEEA4F2E3774Q38722286-6188D72A-8FB6-4708-9DEF-88B44A8763E1Q38906931-143BD5A2-22C2-4A06-97BE-84AAD42ACC2FQ39045197-EBFDD331-16EB-4F62-B57C-031C4F4061A0Q39293769-4F822687-49C8-4B21-83E6-A44B657DC907Q40032975-9208DD88-1825-49BE-B67C-D8EF43276732Q40585831-F2D9CAAE-4C56-4269-90F2-9D771A69F1DCQ40591348-7EA33E51-B68C-477B-8492-179940EE3FBEQ40625237-19FD6DEB-46E8-4F00-B574-47166868E56FQ41895634-846820DE-BE20-46EF-A9C3-22ABB57DE781Q42783210-65BDEB21-40F8-4A33-8ABC-9DFF412167C2Q44076578-486D834C-A194-4127-A03F-0C38F5D1E2B9Q47662148-E46BEFB2-4AC3-464C-A8A4-AED568292D3EQ47874050-C28C78B3-E4AD-4EB3-88E7-CF62F75340EDQ48004310-90EB59D4-F6A6-4E9A-B033-7DB1807A91FBQ48044394-9B1D9EC0-FC8F-4462-87F7-4ED2726EADB1Q50075623-468BB756-A4E5-4F04-97AD-70193B3B5F09Q50207825-F62201E1-939F-4A20-ADFD-C075DAAB04BEQ50866044-9BCA9E66-5A92-472C-BE7D-7F3DA70CCAF5Q55355659-9BC60CEE-43FD-4AC0-A173-58C3D86D1C7DQ57174329-42D5774A-B41D-488B-A71D-A4C729D40F66Q58130744-EFC70CA1-531E-46C0-B4D0-958FEA43FECD
P2860
Range uncertainty in proton therapy due to variable biological effectiveness.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Range uncertainty in proton therapy due to variable biological effectiveness.
@en
Range uncertainty in proton therapy due to variable biological effectiveness.
@nl
type
label
Range uncertainty in proton therapy due to variable biological effectiveness.
@en
Range uncertainty in proton therapy due to variable biological effectiveness.
@nl
prefLabel
Range uncertainty in proton therapy due to variable biological effectiveness.
@en
Range uncertainty in proton therapy due to variable biological effectiveness.
@nl
P2093
P356
P1476
Range uncertainty in proton therapy due to variable biological effectiveness.
@en
P2093
Alejandro Carabe
Harald Paganetti
Maryam Moteabbed
Nicolas Depauw
P304
P356
10.1088/0031-9155/57/5/1159
P577
2012-02-14T00:00:00Z